EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Exchange Traded Concepts LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD
OFI Invest Asset Management Has $42.01 Million Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. $GILD Holdings Reduced by U.S. Capital Wealth Advisors LLC - Daily Political
Wall Street Zen Downgrades Gilead Sciences (NASDAQ:GILD) to Buy - Markets Daily
Wedge Capital Management L L P NC Sells 59,085 Shares of Gilead Sciences, Inc. $GILD
First Bank & Trust Sells 4,494 Shares of Gilead Sciences, Inc. $GILD - Daily Political
GILD: Extended HIV Exclusivity Will Support Stronger Long-Term Earnings Power
Gilead (GILD): Revisiting Valuation After HIV Wins and New U.S. Drug Pricing Agreement
Gilead Sciences (NASDAQ:GILD) Cut to "Buy" at Wall Street Zen
TrumpRx explained: How Trump's new drug price deals with 9 pharma companies could save patients money
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases
Agreement addresses all requests by President Trump to reduc
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
Voya Investment Management LLC Purchases 426,743 Shares of Gilead Sciences, Inc. $GILD
NatWest Group plc Trims Position in Gilead Sciences, Inc. $GILD
Czech National Bank Acquires 11,080 Shares of Gilead Sciences, Inc. $GILD
Does Gilead Still Offer Value After Its 2025 Surge and Pipeline Progress?
Assenagon Asset Management S.A. Buys 2,169,266 Shares of Gilead Sciences, Inc. $GILD
Insider Selling: Gilead Sciences (NASDAQ:GILD) Insider Sells 3,000 Shares of Stock
Gilead Sciences (NASDAQ:GILD) CFO Andrew Dickinson Sells 3,000 Shares
Gilead Sciences Inc. (GILD) - Insider Monkey
Gilead Sciences, Inc. $GILD Shares Bought by Westwood Holdings Group Inc.
Gilead Sciences, Inc. $GILD Shares Sold by Texas Permanent School Fund Corp
Gilead Sciences, Inc. $GILD Shares Acquired by Orion Porfolio Solutions LLC
Kestra Investment Management LLC Acquires 9,551 Shares of Gilead Sciences, Inc. $GILD
National Bank of Canada FI Reduces Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences Reports Positive Phase 3 ARTISTRY-2 HIV Trial Results
Farmers Trust Co. Sells 11,071 Shares of Gilead Sciences, Inc. $GILD
Westwood Holdings Group Inc. Boosts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer
Thrivent Financial for Lutherans Sells 238,111 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Stock Position Trimmed by China Universal Asset Management Co. Ltd.
Kentucky Retirement Systems Decreases Stake in Gilead Sciences, Inc. $GILD - Daily Political
6,279 Shares in Gilead Sciences, Inc. $GILD Purchased by Rexford Capital Inc. - Daily Political
Why Arcus Biosciences (RCUS) Is Down 15.4% After Ending Key Gastric Cancer Trial And Pivoting Pipeline
Is Earlier Yescarta Use in Lymphoma Altering The Investment Case For Gilead Sciences (GILD)?
Gilead Sciences, Inc. $GILD Stock Position Decreased by Benjamin Edwards Inc. - Markets Daily
Gilead Sciences, Inc. $GILD Shares Sold by Benjamin Edwards Inc.
AQR Capital Management LLC Has $272.21 Million Stake in Gilead Sciences, Inc. $GILD
Ameriprise Financial Inc. Boosts Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by Adage Capital Partners GP L.L.C.
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00 - Markets Daily
Morgan Stanley Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - Stock Observer
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $150.00 - Stock Observer
BlueCrest Capital Management Ltd Buys Shares of 13,553 Gilead Sciences, Inc. $GILD - Daily Political
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
Stock Traders Buy Large Volume of Gilead Sciences Call Options (NASDAQ:GILD)
Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD) - Markets Daily
Arcus Biosciences Shares Drop 12% After Discontinuing Phase 3 STAR-221 Trial
Arcus, Gilead to Discontinue Phase 3 Trial of Potential Cancer Treatment - Update | Morningstar
Arcus Biosciences And Gilead Discontinue Phase 3 STAR-221 Study In Cancer Due To Futility
Gilead, Arcus scrap late-stage trial of cancer drug combo - Yahoo News Canada
Gilead Sciences, Inc. $GILD Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Sei Investments Co. Raises Stock Holdings in Gilead Sciences, Inc. $GILD
NewEdge Advisors LLC Has $11.81 Million Stock Position in Gilead Sciences, Inc. $GILD
Alliancebernstein L.P. Sells 809,531 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $151.00 at Morgan Stanley - Daily Political
Fota's Fergal Harte: 'We're having debates about food menus because of the cost of beef'
Arcus shifts effort, bears down on would-be 'anchor' in RCC | BioWorld
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
CIBC Asset Management Inc Sells 28,874 Shares of Gilead Sciences, Inc. $GILD
The Manufacturers Life Insurance Company Sells 95,568 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (GILD) Gets a Buy from Wells Fargo | Markets Insider
Gilead Sciences, Inc. $GILD Stake Decreased by Intact Investment Management Inc. - Daily Political
Cantor Fitzgerald Maintains a Buy Rating on Gilead Sciences (GILD)
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00 at HSBC
Wells Fargo & Company Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Kalaris Therapeutics Inc. $KLRS Shares Sold by Gilead Sciences Inc.
30,000 Shares in Gilead Sciences, Inc. $GILD Bought by Diadema Partners LP
Lombard Odier Asset Management Switzerland SA Raises Position in Gilead Sciences, Inc. $GILD - Markets Daily
State Street Corp Sells 335,515 Shares of Gilead Sciences, Inc. $GILD
Ossiam Sells 15,066 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Investment Management Corp of Ontario - Stock Observer
Daiwa Securities Group Inc. Has $40.24 Million Stake in Gilead Sciences, Inc. $GILD - Daily Political
- 98% reduction in HSV-2 shedding rate, >99% reduction in
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
35,296 Shares in Gilead Sciences, Inc. $GILD Bought by SVB Wealth LLC
WINTON GROUP Ltd Invests $5.02 Million in Gilead Sciences, Inc. $GILD - Stock Observer
Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis
- Benefits Seen Regardless of Eligibility for Previous Stand
Federated Hermes Inc. Sells 1,885,664 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Position Decreased by Brown Advisory Inc.
Gilead Sciences, Inc. $GILD Shares Sold by Baird Financial Group Inc.
Why The Narrative Around Gilead Sciences Is Shifting After HIV And Oncology Updates
California Public Employees Retirement System Has $462.95 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Pharmaceutical Stocks To Watch Today - December 6th - Markets Daily
- Initial Results from Kite-753, Optimized with Novel Manufa
- 96% Overall Response Rate, 74% Stringent Complete Response
First Trust Advisors LP Sells 1,512,069 Shares of Gilead Sciences, Inc. $GILD
Gilead News
AI Chip Stocks to Watch in 2026: Nvidia (NVDA) Stock, Alphabet Stock, INTC
Trending tech stock analysis: What’s driving CoreWeave (CRWV) stock prices?
XRP (Ripple) price prediction: Will XRP soar like Bitcoin (BTC/USD) in 2026?
Ethereum Price (ETH/USD) Forecast: How high is ETH expected to go in 2026?
